← Home
📢 Press Releases
| Date | Press release |
|---|---|
| 2026-03-25 06:30:00 | Bio-techne Advances Spatial Biology With Modular Expansion Of Comet™ Suite New spyre™ focus panels (stroma and vessel) broaden modular panel options, enabling deeper targeted insights in spatial biology workflows. spyre™ amplification kits leverage sequential and enhanced layered amplification (seqla™) technology enabling improved detection of low-abundance and challenging targets. |
| 2026-02-26 01:01:00 | Cmb.tech Announces Q4 2025 Results - Eight Vlccs Sold At Stellar Prices Cmb.tech announces q4 2025 results eight vlccs sold at stellar prices antwerp, belgium, 26 february 2026 – cmb.tech nv (“cmbt”, “cmb.tech” or “the company”) (nyse: cmbt, euronext brussels: cmbt and euronext oslo bØrs: cmbto) reported its unaudited financial results today for the fourth quarter ended 31 december 2025. highlights financial highlights: profit for the period of usd 90.1 million in q4 2025. |
| 2026-02-24 07:00:00 | Bio-techne To Present At Upcoming Investor Conferences Minneapolis, feb. 24, 2026 /prnewswire/ -- bio-techne corporation (nasdaq: tech) today announced that it will present at the following investor conferences: td cowen 46th annual health care conferencemarch 3, 202611:10 am est leerink partners global healthcare conferencemarch 10, 20268:40 am edt a live webcast of the presentations can be accessed via the ir calendar page of bio-techne’s investor relations website at https://investors.bio-techne.com/ir-calendar. about bio-techne bio-techne corporation (nasdaq: tech) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. |
| 2026-02-16 06:30:00 | Bio-techne’s Ella Platform Achieves Ce-ivd Marking Expanding Access To Rapid, Cartridge‑based Immunoassays For European Clinical Laboratories Ella benchtop instrument is now ce-ivd marked and available for sale in the eu enables diagnostic assay developers to leverage a simplified platform that delivers speed and reproducible results with minimal hands-on time provides confidence for use in clinical trials and in-house test development minneapolis , feb. 16, 2026 /prnewswire/ -- bio-techne corporation (nasdaq: tech), a global provider of life science tools, reagents, and diagnostic products, today announced that the ella benchtop immunoassay platform has received ce-ivd marking1 and is now available for sale in the european union. this achievement brings ella’s hallmark ease of use, speed and reproducibility to clinical settings, helping laboratories streamline workflows and support timely decision-making. |
| 2026-02-12 02:15:00 | Cmb.tech Announces Q4 2025 Results On 26/02/2026 Antwerp, feb. 12, 2026 (globe newswire) -- cmb.tech nv (nyse: cmbt & euronext: cmbt) (“cmbt”, “cmb.tech” or “the company”) will release its fourth quarter 202 5 earnings prior to market opening on thursday 26 february 202 6 and will host a conference call at 8 a.m. est / 2 p.m. cet to discuss the results for the quarter. |
| 2026-02-11 09:00:00 |
|
| 2026-02-04 06:30:00 |
|
| 2026-02-02 06:30:00 |
|
| 2026-01-28 06:30:00 |
|
| 2026-01-20 07:00:00 |
|
| 2026-01-08 15:00:00 |
|
| 2026-01-07 16:07:00 |
|
| 2025-12-23 07:00:00 |
|
| 2025-12-16 02:27:00 |
|
| 2025-12-09 06:30:00 |
|
📰 Browse additional press releases for Bio-Techne!
Sign up for free or log in🆓 Discover "The Checklist Value Investor — A Smarter Way to Pick Stocks" — free eBook!